Navigation Links
Genmab Amends Ofatumumab Pivotal Study in NHL to Single Arm Study
Date:9/27/2007

Summary: Genmab has Amended the Design of the Ofatumumab Pivotal Study in Rituximab Refractory Follicular Non-Hodgkin's lymphoma and Reduced the

Number of Patients to Approximately 81

COPENHAGEN, September 27 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today it has amended the design of an ongoing pivotal study of ofatumumab (HuMax-CD20(R)) in rituximab refractory follicular non-Hodgkin's lymphoma (NHL) to a single arm trial that will now include approximately 81 patients. All patients will receive one infusion of 300 mg of ofatumumab followed by 7 weekly infusions of 1000 mg of ofatumumab. The original study design included 162 patients, who would have received one infusion of 300 mg of ofatumumab followed by 7 weekly infusions of either 500 or 1000 mg of ofatumumab. This is the first study of ofatumumab dedicated to patients with rituximab-refractory follicular lymphoma.

In order to establish that ofatumumab is efficacious in this refractory setting, reducing the number of patients in the trial will help to expedite a result. The lower dose (500 mg) was dropped to reduce the total number of patients to be accrued and ensure that these very sick patients receive the maximum dose. Data from patients who were already treated in the 500 mg dose group will be analyzed for safety and included in the secondary efficacy analysis, but will not be included in the primary efficacy analysis.

"This change to the pivotal study design will allow us to treat all the refractory patients with a higher dose level of ofatumumab, allowing the maximum opportunity for response and longer lasting effects in this patient population," said Lisa N. Drakeman, Ph.D., Chief Executive Officer of Genmab. Ofatumumab is an investigational drug being developed under a co-development and commercialization agreement between Genmab and GlaxoSmithKline. It is not yet approved in any market.

About Genmab A/S

Genmab is a leading int
'/>"/>

SOURCE Genmab A/S
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Antibodies for Studying NMDA Receptor Protein Expression and Synapse-Specific Immunolabeling
2. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
3. Enzyme Immunoassay for Studying Intracellular Levels of cAMP
4. RT-PCR Primers for the Study of Apoptosis
5. A Comparison Study of Lipid Tranfection Reagents in A549, NIH 3T3 and COS-7 Cell Lines
6. New Reporter Plasmids for Studying Interferon-Stimulated Signal Transduction Pathways
7. New Fusion Trans-Activator Plasmids for Studying Signal Transduction Pathways
8. Medical College receives $377K to study brain disease
9. Kauffman study shows consistent entrepreneurial growth
10. Study affirms information technology-productivity link
11. Deltanoid Pharmaceuticals begins phase II osteoporosis study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... September 2014 Die zweite jährliche ... 12. bis 18. Oktober stattfinden. Die IPAW ist ... Association (PPTA) und ihrer Mitgliedsunternehmen ... globale Bewusstsein für die Gewinnung von Quellplasma zu ... Retten und Verbessern von Leben zu würdigen ...
(Date:9/15/2014)... 2014 La segunda anual International Plasma Awareness ... 18 de octubre. Como iniciativa conjunta de la Plasma ... miembro s, la IPAW se ha diseñado para: ... colección de fuentes de plasma , Reconocimiento de las ... las vidas , Aumento del conocimiento sobre salvar vidas ...
(Date:9/15/2014)... GA (PRWEB) September 15, 2014 ... http://www.hydrodynamics.com ) announced today that it will be ... Estates, CA ( http://www.proteaf.com ) for implementing its ... high value continuous processing. Continuous flow chemistry ... the chemical, pharmaceutical and petrochemical markets for decades. ...
(Date:9/14/2014)... in a wide variety of ways, including by modifying ... take on another form and perform no or even ... can cause serious diseases such as Alzheimer,s, Parkinson,s or ... tendency to "infect" other molecules of the same type ... These amyloids can damage cells and tissues and make ...
Breaking Biology Technology:International Plasma Awareness Week feiert Spender und rückt seltene Krankheiten in den Mittelpunkt 2International Plasma Awareness Week feiert Spender und rückt seltene Krankheiten in den Mittelpunkt 3La International Plasma Awareness Week será una celebración para los donantes 2La International Plasma Awareness Week será una celebración para los donantes 3Hydro Dynamics Partners with the Continuous Flow Chemistry Experts of Proteaf Technologies 2Measuring modified protein structures 2Measuring modified protein structures 3
... ... management, NEW ... CAXG), which has the largest,manufacturing facility and product pipeline for highly ... China,State Food & Drug Administration (SFDA) granted the Company the designated,manufacturer ...
... ROCKVILLE, Md., Nov. 26 Human Genome,Sciences, Inc. (Nasdaq: ... the,Piper Jaffray 19th Annual Health Care Conference will be ... (Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO ), A member of ... of the company on Wednesday, November 28, 2007 at ...
... Ability to Integrate with Multiple Disparate PACS ... ... Turnaround, CHICAGO, Nov. 26 RSNA Booth #5924 ... connectivity and,interoperability between diagnostic acquisition devices, PACS, HIS, RIS,and ...
Cached Biology Technology:China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 2China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 3China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 4E-Rad Solutions Selects Compressus' Enterprise Systems Integration Technology to Fuel Entry Into Teleradiology Market 2E-Rad Solutions Selects Compressus' Enterprise Systems Integration Technology to Fuel Entry Into Teleradiology Market 3
(Date:9/15/2014)... Earth for the first 500 million years after it ... day, complete with oceans, continents and active crustal plates. ... called the Hadean, has gained substantial new support from ... more than 4 billion years ago with those formed ... possible geological analog for early Earth. , The study ...
(Date:9/15/2014)... of the cheetah: The big predator is the fastest land ... just a few seconds. As it ramps up to top ... it reaches a full gallop. , Now MIT researchers have ... a robotic cheetah a sleek, four-legged assemblage of gears, ... its feline counterpart. The team recently took the robot for ...
(Date:9/15/2014)... wild, domesticated, and domesticated-wild hybridized populations of ... that within 5 to 11 generations, selection ... populations that hybridized with domesticated populations. , ... evidence that natural selection, over time, removes ... as a result of increased genetic diversity. ...
Breaking Biology News(10 mins):Early Earth less hellish than previously thought 2Early Earth less hellish than previously thought 3Run, cheetah, run 2Run, cheetah, run 3
... a multi-institutional study led by Cincinnati Childrens Hospital ... stubborn solid tumor cancers neuroblastoma and peripheral ... inserting instructions to inhibit tissue growth into an ... the February 15 Cancer Research. Malignant ...
... a one-celled, planktonic marine organism, reported today (Thursday, ... telling scientists about the evolutionary changes that accompanied ... animals like ourselves. In the Nature paper ... week, University of California, Berkeley, biologists Nicole King, ...
... the ideal environmentally friendly energy source, it would be a ... that does not pollute our air when burned. That is ... in a new program that uses bacteria and sunlight to ... The project is one of the first to ...
Cached Biology News:Tumor-targeting viral therapy slows neuroblastoma, malignant peripheral nerve sheath tumors 2Genome of marine organism tells of humans' unicellular ancestors 2Genome of marine organism tells of humans' unicellular ancestors 3Genome of marine organism tells of humans' unicellular ancestors 4Project focuses on production of hydrogen from bacteria and sunlight 2Project focuses on production of hydrogen from bacteria and sunlight 3Project focuses on production of hydrogen from bacteria and sunlight 4
Human Glypican 2 Biotinylated Affinity Purified PAb...
Human Contactin-2/TAG1 Affinity Purified Polyclonal Ab...
Tachykinin (H-2)...
Human BMP 2 Construction Kit provides antigen affinity purified polyclonal capture and tracer antibodies, and antigen standard for development of approximately ten microplate assays....
Biology Products: